Omega XL Reports New Independent Study: DHA During Pregnancy Decreased Colds in Children

A recent independent study published online in Pediatrics concluded that omega-3 DHA supplementation, such as that found in Omega XL®, during pregnancy decreased the occurrence of colds in children at 1 month and reduced illness symptom duration up to 6 months of age.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
researchers concluded that omega-3 DHA supplementation during pregnancy was statistically significant in decreasing the occurrence of colds in children from birth up to 6 months

Fort Lauderdale, FL (PRWEB) June 19, 2012

The long-chain polyunsaturated fatty acid, docosahexaenoic acid (DHA), such as found in Omega XL, influences immune function and inflammation; however, the influence of maternal DHA supplementation on infant illnesses is unknown. Recently, researchers in a multi-clinical trial investigated the effects of prenatal DHA supplementation on the common cold in infants.
In a double-blind randomized controlled trial, pregnant women received daily supplementation with 400 mg of DHA or placebo from 18 to 22 weeks of pregnancy through childbirth.

Data were available at 1, 3, and 6 months for 849, 834, and 834 infants, respectively. At 1 month, the DHA group experienced 26%, 15%, and 30% shorter duration of cough, phlegm, and wheezing, respectively. At 3 months, infants in the DHA group spent 14% less time ill. At 6 months, infants in the DHA group experienced 20%, 13%, 54%, 23%, and 25% shorter duration of fever, nasal secretion, difficulty breathing, rash, and “other illness,” respectively.

Considering the relatively large population of infants studied, the researchers concluded that omega-3 DHA supplementation during pregnancy was statistically significant in decreasing the occurrence of colds in children from birth up to 6 months of age.

Omega XL is a bestselling Omega 3 supplement that contains the patented stabilized marine lipid extract PCSO-524™ derived only from the New Zealand green-lipped mussel with 30 healthy fatty acids including DHA and EPA. Omega XL, manufactured exclusively by Great HealthWorks Inc., is the most widely available omega-3 fish oil supplement containing the potent PCSO-524™ marine lipid extract. To find more information about Omega XL and PCSO-524™ visit http://www.OmegaXL.com

Source: Pediatrics
Prenatal Docosahexaenoic Acid Supplementation and Infant Morbidity: Randomized Controlled Trial

http://pediatrics.aappublications.org/content/early/2011/07/28/peds.2010-1386

About Great HealthWorks, Inc.
Great HealthWorks, founded in 2003, is a global manufacturer and distributor of one-of-a-kind, natural products. Great HealthWorks, the makers of Omega XL, an all-natural, highly purified marine lipid extract from the green-lipped mussel (Perna Canaliculus) known as PCSO-524™. This patented marine lipid complex comes exclusively from the pristine waters of the Marlborough Sounds in New Zealand, and contains the most concentrated array of omega-3 free fatty acids available. Great HealthWorks corporate headquarters and distribution center are in Hollywood, Florida. To find out more about Great HealthWorks, visit http://www.GreatHealthWorks.com. And for more information about the benefits of Omega XL, visit http://www.OmegaXL.com. Join the conversation: http://www.facebook.com/myomegaxl


Contact